November 29, 2016 - By Hazel Jackson · 0 Comments
The stock of Cantel Medical Corporation (NYSE:CMN) registered an increase of 9.53% in short interest. CMN’s total short interest was 884,100 shares in November as published by FINRA. Its up 9.53% from 807,200 shares, reported previously. With 134,400 shares average volume, it will take short sellers 7 days to cover their CMN’s short positions. The short interest to Cantel Medical Corporation’s float is 2.52%. About 92,715 shares traded hands. Cantel Medical Corp. (NYSE:CMN) has risen 16.68% since April 26, 2016 and is uptrending. It has outperformed by 11.42% the S&P500.
Cantel Medical Corp. is a provider of infection prevention services and products in the healthcare market. The company has a market cap of $3.34 billion. The Company’s operating divisions include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. It has a 56.31 P/E ratio. The Company’s Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies.
Insitutional Activity: The institutional sentiment decreased to 0.95 in 2016 Q2. Its down 0.36, from 1.31 in 2016Q1. The ratio dived, as 20 funds sold all Cantel Medical Corp. shares owned while 65 reduced positions. 32 funds bought stakes while 79 increased positions. They now own 32.47 million shares or 5.14% less from 34.23 million shares in 2016Q1.
Deutsche State Bank Ag has 0% invested in the company for 47,112 shares. Janney Montgomery Scott Limited Liability Company holds 13,245 shares or 0.01% of its portfolio. Evercore Wealth Limited Company holds 0.07% of its portfolio in Cantel Medical Corp. (NYSE:CMN) for 21,600 shares. Moreover, Thompson Davis And Co has 0.61% invested in Cantel Medical Corp. (NYSE:CMN) for 5,586 shares. Conestoga Advsr Ltd Liability accumulated 3.09% or 608,180 shares. Commonwealth Equity Service has 0.01% invested in the company for 11,724 shares. Tower Cap Limited Liability (Trc), a New York-based fund reported 4,905 shares. The Michigan-based Connable Office Incorporated has invested 0.08% in Cantel Medical Corp. (NYSE:CMN). Fifth Third Bancorporation holds 70 shares or 0% of its portfolio. The Texas-based Dimensional Fund Advisors Lp has invested 0.05% in Cantel Medical Corp. (NYSE:CMN). Congress Asset Ma holds 0.11% or 67,042 shares in its portfolio. Public Employees Retirement Association Of Colorado last reported 0.22% of its portfolio in the stock. Eagle Asset owns 100,778 shares or 0.05% of their US portfolio. Allianz Asset Ag has 0.01% invested in the company for 232,873 shares. Suntrust Banks Inc holds 0% of its portfolio in Cantel Medical Corp. (NYSE:CMN) for 5,949 shares.
Insider Transactions: Since June 10, 2016, the stock had 0 insider buys, and 6 sales for $2.64 million net activity. $187,823 worth of Cantel Medical Corp. (NYSE:CMN) was sold by NODIFF ERIC W. On Monday, October 10 the insider ANAYA STEVEN C sold $423,877. Shares for $513,111 were sold by Diker Mark N. on Friday, June 10. The insider DIKER CHARLES M sold 3,000 shares worth $226,841. The insider BERMAN ANN E sold $112,698.
Out of 2 analysts covering Cantel Medical (NYSE:CMN), 1 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 50% are positive. Cantel Medical has been the topic of 2 analyst reports since August 24, 2016 according to StockzIntelligence Inc. Benchmark initiated the stock with “Buy” rating in Monday, August 29 report. The company was initiated on Wednesday, August 24 by Needham.
Cantel Medical Corp., incorporated on August 16, 1963, is a well-known provider of infection prevention services and products in the healthcare market. The Company’s operating divisions include Endoscopy; Water Purification and Filtration; Healthcare Disposables, and Dialysis. The Company’s Endoscopy segment includes medical device reprocessing systems, disinfectants, detergents and other supplies. The Company’s Water Purification and Filtration segment includes water purification equipment and services, filtration and separation products, and disinfectant, sterilization and decontamination services and products. The Company’s Healthcare Disposables segment includes single-use, infection prevention and control healthcare products. The Company’s Dialysis segment includes medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis.
More notable recent Cantel Medical Corp. (NYSE:CMN) news were published by: Marketwatch.com which released: “Cantel Medical Corp initiated at buy rating, $83 price target at Benchmark” on December 21, 2009, also Prnewswire.com with their article: “Cantel Medical Expands its Direct Sales Operations in Canada through the …” published on September 26, 2016, Prnewswire.com published: “Cantel Medical Acquires Accutron, Inc.” on August 01, 2016. More interesting news about Cantel Medical Corp. (NYSE:CMN) were released by: Prnewswire.com and their article: “Cantel Medical to Present at the Stifel 2016 Healthcare Conference” published on November 01, 2016 as well as Quotes.Wsj.com‘s news article titled: “News Cantel Medical Corp.CMN” with publication date: February 11, 2011.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Hazel Jackson